MMP9 and neoplasm: Before tumor cells reach premetastatic sites, MDSCs significantly decrease IFN-γ levels; increase proinflammatory cytokine and matrix metalloproteinase 9 (MMP9) production; and promote vascular remodeling, thereby forming an inflammatory and immunosuppressive environment48.